Banque Transatlantique SA Sells 8,100 Shares of Danaher Corporation $DHR

Banque Transatlantique SA trimmed its holdings in Danaher Corporation (NYSE:DHR) by 3.4% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 227,664 shares of the conglomerate’s stock after selling 8,100 shares during the quarter. Danaher accounts for about 1.1% of Banque Transatlantique SA’s holdings, making the stock its 19th biggest holding. Banque Transatlantique SA’s holdings in Danaher were worth $44,854,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. WFA of San Diego LLC purchased a new position in Danaher in the 2nd quarter worth $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher during the second quarter valued at about $27,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher during the third quarter valued at about $27,000. TruNorth Capital Management LLC bought a new position in shares of Danaher during the third quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC purchased a new position in shares of Danaher in the third quarter worth about $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.6%

Shares of Danaher stock opened at $187.34 on Friday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The company’s 50 day moving average is $218.79 and its 200 day moving average is $215.34. The company has a market cap of $132.47 billion, a price-to-earnings ratio of 37.17, a price-to-earnings-growth ratio of 2.52 and a beta of 0.93.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.14 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.40 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio is currently 25.40%.

Analyst Ratings Changes

DHR has been the subject of several analyst reports. TD Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. HSBC increased their price objective on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Robert W. Baird set a $251.00 target price on shares of Danaher in a research note on Thursday, January 29th. Finally, Evercore reissued an “outperform” rating and set a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $253.55.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.